Month: March 2023

Public Comment to the Department of Commerce, Economic Development Administration

March 20, 2023 | Lars Schönander

Today, I submitted a public comment to the Economic Development Administration concerning its proposed rules for the Implementation of the Regional Technology and Innovation Hub Program. My name is Lars Erik Schönander. I am a Policy Technologist at Lincoln Network. I appreciate the opportunity to provide public comment to the U.S. Economic Development Administration (EDA)

March 15, 2023 | Jonathon Hauenschild

This piece was originally published in the Washington Times. The Senate Judiciary Committee recently grilled Attorney General Merrick Garland over a wide range of issues, including the FBI’s targeting of traditional Catholics and the treatment of pro-life activists, while ignoring violence against crisis pregnancy centers. Likewise, the House Committee on the Weaponization of the Federal Government

March 14, 2023 | Jimmy Soni

This piece was originally published in The Dispatch. On an SAT answer bubble, a single vertical mark through a letter counts as a response. Why does that matter? Because drawing a short line requires two fewer seconds than shading a full bubble. Across dozens of questions, that’s precious minutes saved. I absorbed this piece of testing

March 8, 2023 | Luke Hogg

This piece was originally published in Tech Policy Press. From education to media to medicine, the rapid development of artificial intelligence tools has already begun to upend long-established conventions. Our democratic institutions will be no exception. It’s therefore crucial that we think about how to build AI systems in a way that democratically distributes the benefits.

Who Owns the Farm in the U.K.?

March 6, 2023 | Lars Schönander

As U.S.-China competition heats up, lawmakers are realizing the extent to which Chinese companies and investments threaten U.S. national security. But this isn’t just an American issue; British policymakers should be aware of similar risks to their own country. In particular, the U.K. has a chance to learn from the latest U.S. area of focus:

March 3, 2023 | Satya Thallam

This piece was originally published in The Hill. Early last year, an FDA advisory committee rejected a new lung cancer drug. The reason? They weren’t too keen on foreign clinical data. Later in the year, the developer of a potential variant-proof COVID-19 treatment that might even be effective against other viruses faced the same problem. The FDA rejected

March 1, 2023 | Luke Hogg

Today, Zach Graves, Executive Director of Lincoln Network, and figures from three other organizations, sent a letter to Speaker McCarthy and members of the House Republican Conference, recommending that they strengthen the legislative branch and its capacity for policymaking and oversight in the 118th Congress. The text of the letter reads: Dear Speaker McCarthy and members of